A Worrying Lesson from Danone for Reckitt’s Fading Glory: Gadfly
A Worrying Lesson from Danone for Reckitt’s Fading Glory: Gadfly
/ May 22, 2017 / 0 comments

Apr 21, 2017 – 11:38 (Bloomberg Gadfly) — Two big consumer groups engaged in transformative M&A: two disappointments. Reckitt Benckiser Group Plc, which agreed to buy Mead Johnson Nutrition Co. for $16.6 billion earlier this year, announced flat like-for-like sales expansion on Friday. That is the first time ever that the company has failed to…

60 Other Common Drugs Found To Be ‘Substandard’ and lack quality
60 Other Common Drugs Found To Be ‘Substandard’ and lack quality
/ May 19, 2017 / 0 comments

By Sneha Singh – April 22, 2017/The Tecake The Central Drugs Standard Control Organization (CDSCO) has discovered prevalent painkiller Combiflam and icy pharmaceutical D Cold Total, produced and sold by Sanofi India and Reckitt Benckiser Healthcare India, separately, to be substandard in its tests done a month ago. In addition, Cipla’s Oflox-100 DT tablets and…

Six ways to build a robust culture of compliance
Six ways to build a robust culture of compliance
/ May 8, 2017 / 0 comments

Marketing Magazine, Australia—No matter how prominent your brand or how big your budget, over-promising in your advertising or being a tad too clever with your choice of words, is playing with fire. In the worst-case scenario your brand promise will go up in smoke, along with your profits. Reckitt Benckiser’s Nurofen Nurofen is a case…

CSS Calls for Review of Reckitt Benckiser/Mead Johnson Deal
CSS Calls for Review of Reckitt Benckiser/Mead Johnson Deal
/ March 2, 2017 / 0 comments

RB Past Actions Raises Doubts in Preserving Consumer Safety LOS ANGELES, Calif. – (Feb. 28, 2017) – Calling into question a proposed $16.6 billion acquisition of U.S. baby food maker Mead Johnson Nutrition Co. (MJN.N) by British conglomerate Reckitt Benckiser Group Plc (RB.L), the Consumer Safety Coalition urged U.S. Attorney General Jeff Sessions to begin…

Under the pricing spotlight, pharma sticks to single-digit hikes in 2017
Under the pricing spotlight, pharma sticks to single-digit hikes in 2017
/ February 28, 2017 / 0 comments

It’s evidence to justify pharma’s current fears. Amid all of the recent scrutiny on drug pricing—and after enjoying years of great pricing freedom in the U.S.—drugmakers have reined in their price hikes since the start of 2017. And that may threaten this year’s revenue. Citing analysts at Raymond James, The Wall Street Journal reports that just…

Britax voluntarily recalls 676,000 strollers after 26 children reported injured
Britax voluntarily recalls 676,000 strollers after 26 children reported injured
/ February 28, 2017 / 0 comments

Childcare product manufacturer Britax is voluntarily recalling 676,000 strollers in the United States after discovering the car seat on their B-Agile and BOB Motion strollers may disengage and cause a fall to the child, according to federal safety officials. The Consumer Product Safety Commission announced today that “Britax has announced 33 reports” of incidents that…